The latest findings in aging research indicate that addressing the root mechanisms of aging as therapeutic targets might lead to treatments that postpone or prevent age-related diseases, thus extending the healthy period of life. Rejuvenation biotechnology holds huge potential, but it is clearly facing unique financial, development, and regulatory bottlenecks, making it hard for young companies in this sector to take off.